Skip to main content

Table 1 Levels of cytokines IL-1, IL-6, and TNF-α in Wistar rats at 25 day after AIA initiation

From: Anti-inflammatory effect of different curcumin preparations on adjuvant-induced arthritis in rats

Group Sex IL-1, pg/ml 95% CI IL-6, pg/ml 95% CI TNF-α,
pg/ml
95% CI
Control - Male < 31.3 0 - < 31.3 < 31.3 0 - < 31.3 < 39.1 0 - < 39.1
Male < 31.3 0 - < 31.3 < 31.3 0 - < 31.3 < 39.1 0 - < 39.1
Female < 31.3 0–31.3 < 31.3 0 - < 31.3 < 39.1 0 - < 39.1
Female < 31.3 < 31.3–50.1 < 31.3 < 31.3–56.9 < 39.1 0 - < 39.1
Control + Male 33.8 < 31.3–76.0 < 31.3 < 31.3–68.1 < 39.1 < 39.1–67.1
Male 54.0 < 31.3–98.0 36.1 < 31.3–73.9 < 39.1 < 39.1–66.9
Female 196.4 155.6–235,4 205.7 170.8–239.4 736.6 767.5–190.5
Female 51.5 < 31.3–95.0 63.7 < 31.3–99.5 226.1 190.5–261.4
LIPO Male < 31.3 < 31.3–39.9 < 31.3 < 31.3–35.4 < 39.1 0 - < 39.1
Male < 31.3 < 31.3–54.0 < 31.3 < 31.3–43.8 < 39.1 0 - < 39.1
Male < 31.3 < 31.3–39.7 < 31.3 0 - < 31.3 < 39.1 0 - < 39.1
Female < 31.3 0 - < 31.3 < 31.3 0 - < 31.3 < 39.1 0 - < 39.1
Female < 31.3 0 - < 31.3 < 31.3 0 - < 31.3 < 39.1 0 - < 39.1
Female 37.9 < 31.3–80.5 < 31.3 < 31.3–61.7 81.1 120.8
MIC Male 41.4 < 31.3–83.0 33.4 < 31.4–72.1 80.9 41.7–118.0
Male 114.9 73.4–155.0 127.7 91.5–162.5 < 39.1 0 - < 39.1
Male < 31.3 0 - < 31.3 < 31.3 0 - < 31.3 202.4 165.0–238.6
Female < 31.3 0 - < 31.3 < 31.3 0 - < 31.3 < 39.1 0 - < 39.1
Female 193.6 152.7–234.2 212.7 177.7–247.1 618.4 585.9–649.4
Female < 31.3 < 31.3–57.4 < 31.3 < 31.3–41.1 < 39.1 < 39.1–75.0
PIP Male 91.5 49.6–134.2 96.9 58.6–132.6 < 39.1 < 39.1–74.0
Male < 31.3 0 - < 31.3 < 31.3 0 - < 31.3 < 39.1 0 - < 39.1
Male < 31.3 < 31.3–61.5 < 31.3 < 31.3–48.1 < 39.1 0 - < 39.1
Female < 31.3 0 - < 31.3 < 31.3 0 - < 31.3 < 39.1 0 - < 39.1
Female < 31.3 0 - < 31.3 < 31.3 0 - < 31.3 < 39.1 < 39.1–52.3
Female 37.7 < 31.3–79.3 < 31.3 0 - < 31.3 < 39.1 0 - < 39.1
BAS Male 79.5 37.2–120.5 70.6 < 31.3–107.3 < 39.1 < 39.1–73.2
Male < 31.3 < 31.3–62.2 < 31.3 < 31.3–50.0 < 39.1 0 - < 39.1
Male 127.1 86.3–168.4 149.5 113.4–184.9 < 39.1 < 39.1–69.3
Female < 31.3 0 - < 31.3 < 31.3 0 - < 31.3 < 39.1 < 39.1–55.9
Female 83.5 40.3–125.6 104.0 67.5–140.3 107.3 69.7–145.9
Female < 31.3 0 - < 31.3 < 31.3 < 31.1–34.1 < 39.1 0 - < 39.1
  1. Data are shown as mean ± 95% confidence interval (CI). Concentrations (pg/ml) were calculated from standard curves plotted against a 5 parameter curve fit. CI 95% was calculated according to the designed model